Literature DB >> 21981615

Alemtuzumab: right drug, right dose?

Richard Haynes1, Peter Friend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981615     DOI: 10.1111/j.1432-2277.2011.01341.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  1 in total

1.  Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction.

Authors:  Annemarie Weissenbacher; Theresa Hautz; Michael Kimelman; Rupert Oberhuber; Hanno Ulmer; Claudia Bösmüller; Manuel Maglione; Stefan Schneeberger
Journal:  J Immunol Res       Date:  2015-06-11       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.